[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371305-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371305-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","interleukin-16-enhances-anti-tumor-immune-responses-by-establishing-a-th1-cell-macrophage-crosstalk-through-reprogramming-glutamine-metabolism-in-mice","Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice","","Interleukin-16 (IL-16) administration enhances anti-tumor immunity by reshaping tumor immune microenvironments. IL-16 increases Th1 polarization by suppressing glutamine catabolism through downregulation of glutaminase in CD4+ T cells, boosting Th1 effector cytokine IFN-γ. It also promotes an IL-16-dependent, Th1-dominant tumor microenvironment that depends on mast-cell–produced histamine, elevating CXCR3 ligands in tumor-associated macrophages and strengthening immune checkpoint blockade effectiveness. Low IL-16 production in cancer patients associates with poorer prognosis and reduced immunotherapy responsiveness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/interleukin-16-enhances-anti-tumor-immune-responses-by-establishing-a-th1-cell-macrophage-crosstalk-through-reprogramming-glutamine-metabolism-in-mice/371305/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/interleukin-16-enhances-anti-tumor-immune-responses-by-establishing-a-th1-cell-macrophage-crosstalk-through-reprogramming-glutamine-metabolism-in-mice/371305.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does IL-16 enhance anti-tumor immune responses?","Question",{"text":63,"@type":64},"IL-16 administration enhances Th1 cell polarization by inhibiting glutamine catabolism in CD4+ T cells, increasing IFN-γ production and improving anti-tumor immunity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does glutamine metabolism play in IL-16’s effect?",{"text":68,"@type":64},"IL-16 suppresses glutamine catabolism by downregulating glutaminase, which reprograms immune cells and supports a Th1-dominant anti-tumor microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is immune checkpoint blockade more effective with IL-16?",{"text":72,"@type":64},"An IL-16-dependent Th1-dominant tumor microenvironment is established through mast cell-produced histamine, leading to increased CXCR3 ligand expression in tumor-associated macrophages and improved ICB therapeutic effectiveness.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371305,1790788430,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article [https://doi.org/10.1038/s41467-025-57603-1](https://doi.org/10.1038/s41467-025-57603-1)  \nInterleukin-16 enhances anti-tumor immune responses by establishing a Th1 cellmacrophage crosstalk through reprogramming glutamine metabolism in mice  \nReceived: 19 March 2024  \n\n| Accepted: 21 February 2025 |\n| --- |\n| |\n| Check for updates |\n\nZhenzhen Wen1,14, Tong Liu 2,14, Xutao Xu1,14, Nandini Acharya3, Zhida Shen4, Yunkun Lu 5, Junjie Xu 5, Ke Guo1, Shuying Shen 6, Yuening Zhao1,  \nPinli Wang7, Shumin Li7, Weiyu Chen8, Hui Li 9, Yimin Ding1, Min Shang 4, Hongshan Guo 10, Yu Hou10, Bijun Cui11, Manlu Shen1, Youling Huang1, Ting Pan12,13, Wang Qingqing 12,13 , Qian Cao 1 , Kai Wang 8  & Peng Xiao 1,12,13   \nOvercoming immunosuppression in the tumor microenvironment (TME) is crucial for developing novel cancer immunotherapies. Here, we report that IL- 16 administration enhances the polarization of T helper 1 (Th1) cells by inhibiting glutamine catabolism through the downregulation of glutaminase in CD4+ T cells and increases the production of Th1 effector cytokine IFN-γ, thus improving anti-tumor immune responses. Moreover, we ﬁnd that establishing an IL-16-dependent, Th1-dominant TME relies on mast cell-produced histamine and results in the increased expression of the CXCR3 ligands in tumorassociated macrophages (TAM), thereby improving the therapeutic effectiveness of immune checkpoint blockade (ICB). Cancer patients exhibit impaired production of IL-16, which correlates with poorer prognosis. Additionally, low IL-16 production is associated with unresponsiveness to immunotherapy in cancer patients. Collectively, our ﬁndings provided new insights into the biological function of IL-16, emphasizing its potential clinical signiﬁcance as a therapeutic approach to augment anti-tumor immunity and sensitize ICB-based cancer immunotherapy.  \nIn recent years, harnessing the host immune system to combat tumors has emerged as a promising strategy in cancer treatment1. Establishing effective anti-tumor responses requires the proper differentiation and function of tumor-inﬁltrating immune cells. A variety of immune cells populate the tumor microenvironment (TME), including myeloid cells (such as macrophages, dendritic cells, neutrophils, and mast cells) and  \nlymphocytes (such as T cells and B cells). The proper functioning of tumor-inﬁltrating immune cells can exert immunosurveillance roles. For example, it is well recognized that a T helper 1 (Th1) -dominant immune microenvironment, characterized by the increased function of Th1 CD4+ T cells, activated CD8+ T cells, and M1-like macrophages, is essential for immune-mediated tumor eradication2,3. However, tumors evolve  \nA full list of afﬁliations appears at the end of the paper. [e-mail:](e-mail: wqq@zju.edu.cn)[ wqq@zju.edu.cn](e-mail: wqq@zju.edu.cn); [caoq@zju.edu.cn](caoq@zju.edu.cn); [kaiw@zju.edu.cn](kaiw@zju.edu.cn); [tulipxp@zju.edu.cn](tulipxp@zju.edu.cn)  \nmultiple mechanisms to re-educate immune cells into pro-tumor phenotypes, such as secreting high levels of immunosuppressive cytokines (e.g., IL-10, TGF-β)4 or creating a hypoxic environment5. In recent years, abnormal metabolic activity has also been identiﬁed as a crucial regulator of tumor-inﬁltrating immune cells. For example, the reduced availability of glucose impaired the anti-tumor function of Th1 cells, macrophages, and CD8+ cytotoxic T cells6–9. In addition to glucose, another key cellular energy source in the TME is glutamine, whose impact on tumor immunity has been attracting increasing attention. Blocking glutamine degradation into glutamate by glutaminase (GLS) inhibitor enhances anti-melanoma activity of T cells10. Importantly, the efﬁcacy ofGLS inhibitors has been tested in clinical trials in the treatment of some cancers, such as renal cancer and lung cancer11,12. Therefore, understanding the molecular determinants of immune suppression in the TME is crucial for creating an effective anti-tumor immune respon","cbCaiivBh621B8en","https://ap.wps.com/l/cbCaiivBh621B8en","pdf",4556065,17,"English","# Overview\n## IL-16 boosts Th1 polarization via glutamine metabolism\n## IL-16-dependent Th1-dominant tumor microenvironment\n## Clinical relevance: IL-16 levels and immunotherapy response","[{\"question\":\"How does IL-16 enhance anti-tumor immune responses?\",\"answer\":\"IL-16 administration enhances Th1 cell polarization by inhibiting glutamine catabolism in CD4+ T cells, increasing IFN-γ production and improving anti-tumor immunity.\"},{\"question\":\"What role does glutamine metabolism play in IL-16’s effect?\",\"answer\":\"IL-16 suppresses glutamine catabolism by downregulating glutaminase, which reprograms immune cells and supports a Th1-dominant anti-tumor microenvironment.\"},{\"question\":\"Why is immune checkpoint blockade more effective with IL-16?\",\"answer\":\"An IL-16-dependent Th1-dominant tumor microenvironment is established through mast cell-produced histamine, leading to increased CXCR3 ligand expression in tumor-associated macrophages and improved ICB therapeutic effectiveness.\"}]","Interleukin-16 enhances anti-tumor immune responses by establishing a Th1 cell-macrophage crosstalk through reprogramming glutamine metabolism in mice | PDF",1790191754,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aa626ab2ea3a6fa0b70b555379591c16.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f3948cc4f77f0887639df88e797e8e4.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f269f3146ebf8eaa8e07d94b6075b247.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72c408e3ab221eadfa3770f83d2d395e.webp",980,1301]